1,321
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Terpinen-4-ol inhibits the proliferation and mobility of pancreatic cancer cells by downregulating Rho-associated coiled-coil containing protein kinase 2

, , , , , , & ORCID Icon show all
Pages 8643-8656 | Received 02 Jan 2022, Accepted 11 Mar 2022, Published online: 24 Mar 2022

References

  • Mizrahi JD, Surana R, Valle JW, et al. Pancreatic cancer. Lancet. 2020;395(10242):2008–2020.
  • Lei S, He Z, Chen T, et al. Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway. J Exp Clin Cancer Res. 2019;38(1):470.
  • Yao W, Maitra A, Ying H. Recent insights into the biology of pancreatic cancer. EBiomedicine. 2020;53:102655.
  • Ariston Gabriel AN, Wang F, Jiao Q, et al. The involvement of exosomes in the diagnosis and treatment of pancreatic cancer. Mol Cancer. 2020;19(1):132.
  • Cao W, Zeng Z, He Z, et al. Hypoxic pancreatic stellate cell-derived exosomal mirnas promote proliferation and invasion of pancreatic cancer through the PTEN/AKT pathway. Aging (Albany, NY). 2021;13(5):7120–7132.
  • Khaw-on P, Banjerdpongchai R. Induction of intrinsic and extrinsic apoptosis pathways in the human leukemic MOLT-4 cell line by terpinen-4-ol. Asian Pac J Cancer Prev. 2012;13(7):3073–3076.
  • Truong VL, Manochai B, Pham TT, et al. Antioxidant and anti-inflammatory activities of zingiber montanum oil in hepg2 cells and lipopolysaccharide-Stimulated RAW 264.7 Macrophages. J Med Food. 2021;24(6):595–605.
  • Nakayama K, Murata S, Ito H, et al. Terpinen-4-ol inhibits colorectal cancer growth via reactive oxygen species. Oncol Lett. 2017;14(2):2015–2024.
  • Wu CS, Chen YJ, Chen JJ, et al. Terpinen-4-ol induces apoptosis in human nonsmall cell lung cancer in vitro and in vivo. Evid Based Complement Alternat Med. 2012;2012:818261.
  • Peng L, Sang H, Wei S, et al. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2. Mol Cancer. 2020;19(1):156.
  • Jiang L, He Y, Shen G, et al. lncRNA HAND2AS1 mediates the downregulation of ROCK2 in hepatocellular carcinoma and inhibits cancer cell proliferation, migration and invasion. Mol Med Rep. 2020;21(3):1304–1309.
  • Ai N, Li B, Li L, et al. MicroRNA-466 inhibits cancer cell migration and invasion in hepatocellular carcinoma by indirectly mediating the downregulation of ROCK2. Exp Ther Med. 2019;18(2):1493–1499.
  • Deng X, Yi X, Huang D, et al. ROCK2 mediates osteosarcoma progression and TRAIL resistance by modulating O-GlcNAc transferase degradation. Am J Cancer Res. 2020;10(3):781–798.
  • Rath N, Morton JP, Julian L, et al. ROCK signaling promotes collagen remodeling to facilitate invasive pancreatic ductal adenocarcinoma tumor cell growth. EMBO Mol Med. 2017;9(2):198–218.
  • Hu J, Wang L, Zhao W, et al. mi-R4435-2HG promotes proliferation and inhibits apoptosis of cancer cells in ovarian carcinoma by upregulating ROCK2. Oncol Lett. 2020;19(2):1305–1309.
  • Roskoski Jr RJ. Properties of FDA-approved small molecule protein kinase inhibitors: a 2022 update. Pharmacol Res. 2022;175:106037.
  • Vennin C, Rath N, Pajic M, et al. Targeting ROCK activity to disrupt and prime pancreatic cancer for chemotherapy. Small GTPases. 2020;11(1):45–52.
  • Xie C, Mao X, Huang J, et al. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res. 2011;39(suppl_2):W316–22.
  • Giunta S. Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020. Cancer Metastasis Rev. 2021;40(3):909–924.
  • Cao W, Zeng Z, Pan R, et al. Hypoxia-related gene FUT11 promotes pancreatic cancer progression by maintaining the stability of PDK1. Front Oncol. 2021;11:675991.
  • Hu Y, Guo M. Synthetic lethality strategies: beyond BRCA1/2 mutations in pancreatic cancer. Cancer Sci. 2020;111(9):3111–3121.
  • Efferth T, Saeed MEM, Kadioglu O, et al. Collateral sensitivity of natural products in drug-resistant cancer cells. Biotechnol Adv. 2020;38:107342.
  • Wang X, Hamann MT. Marine natural products in the discovery and development of potential pancreatic cancer therapeutics. Adv Cancer Res. 2019;144:299–314.
  • Wiśniewski K, Jozwik M, Wojtkiewicz J. Cancer prevention by natural products introduced into the diet-selected cyclitols. Int J Mol Sci. 2020;21(23):8988.
  • Beaver JA, Howie LJ, Pelosof L, et al. A 25-year experience of US Food and Drug Administration accelerated approval of malignant hematology and oncology drugs and biologics: a review. JAMA Oncol. 2018;4(6):849–856.
  • Sanders K, Moran Z, Shi Z, et al. Natural products for cancer prevention: clinical Update 2016. Semin Oncol Nurs. 2016;32(3):215–240.
  • Calibasi-Kocal G, Pakdemirli A, Bayrak S, et al. Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer. J BUON. 2019;24(4):1482–1487.
  • Kalluru H, Kondaveeti SS, Telapolu S, et al. Turmeric supplementation improves the quality of life and hematological parameters in breast cancer patients on paclitaxel chemotherapy: a case series. Complement Ther Clin Pract. 2020;41:101247.
  • Unlu A, Nayir E, Dogukan Kalenderoglu M, et al. Curcumin (Turmeric) and cancer. J BUON. 2016;21(5):1050–1060.
  • Suthisut D, Fields PG, Chandrapatya A. Contact toxicity, feeding reduction, and repellency of essential oils from three plants from the ginger family (Zingiberaceae) and their major components against Sitophilus zeamais and Tribolium castaneum. J Econ Entomol. 2011;104(4):1445–1454.
  • Maquera-Huacho PM, Tonon CC, Correia MF, et al. In vitro antibacterial and cytotoxic activities of carvacrol and terpinen-4-ol against biofilm formation on titanium implant surfaces. Biofouling. 2018;34(6):699–709.
  • Ning J, Xu L, Zhao Q, et al. The protective effects of Terpinen-4-ol on LPS-induced acute lung injury via activating PPAR-gamma. Inflammation. 2018;41(6):2012–2017.
  • Zhang Y, He L, Tu M, et al. The ameliorative effect of terpinen-4-ol on ER stress-induced vascular calcification depends on SIRT1-mediated regulation of PERK acetylation. Pharmacol Res. 2021;170:105629.
  • Banjerdpongchai R, Khaw-On P. Terpinen-4-ol induces autophagic and apoptotic cell death in human leukemic HL-60 cells. Asian Pac J Cancer Prev. 2013;14(12):7537–7542.
  • Rodrigues T, Reker D, Schneider P, et al. Counting on natural products for drug design. Nat Chem. 2016;8(6):531–541.
  • Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14(2):111–129.
  • Sá ACC, Sadee W, Johnson JA. Whole transcriptome profiling: an RNA-Seq primer and implications for pharmacogenomics research. Clin Transl Sci. 2018;11(2):153–161.
  • Stark R, Grzelak M, Hadfield J. RNA sequencing: the teenage years. Nat Rev Genet. 2019;20(11):631–656.
  • Pranatharthi A, Ross C, Srivastava S. Cancer stem cells and radioresistance: rho/ROCK pathway plea attention. Stem Cells Int. 2016;2016:5785786.
  • Kloc M, Uosef A, Kubiak JZ, et al. Role of macrophages and RhoA pathway in atherosclerosis. Int J Mol Sci. 2020;22(1):216.
  • Liu J, Zhu Y, Ge C. LncRNA ZFAS1 promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2 pathway by sponging miR-3924. Cancer Cell Int. 2020;20(1):249.
  • Peng F, Jiang J, Yu Y, et al. Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumorigenesis and metastasis. Br J Cancer. 2013;109(12):3092–3104.